These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25897782)

  • 21. Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Hernandez-Castillo CR; Diaz R; Campos-Romo A; Fernandez-Ruiz J
    Cerebellum Ataxias; 2017; 4():7. PubMed ID: 28593048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinocerebellar Ataxia Type 3: A Case Report and Literature Review.
    McCord MR; Bigio EH; Kam KL; Fischer V; Obeidin F; White CL; Brat DJ; Muller WA; Mao Q
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):641-646. PubMed ID: 32346735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor cortical dysfunction develops in spinocerebellar ataxia type 3.
    Farrar MA; Vucic S; Nicholson G; Kiernan MC
    Clin Neurophysiol; 2016 Nov; 127(11):3418-3424. PubMed ID: 27689815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
    Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
    J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
    Lukas C; Schöls L; Bellenberg B; Rüb U; Przuntek H; Schmid G; Köster O; Suchan B
    Neurosci Lett; 2006 Nov; 408(3):230-5. PubMed ID: 17005321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients.
    Maas RPPWM; Killaars S; van de Warrenburg BPC; Schutter DJLG
    J Neurol; 2021 Sep; 268(9):3456-3466. PubMed ID: 33743045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific cerebellar and cortical degeneration correlates with ataxia severity in spinocerebellar ataxia type 7.
    Hernandez-Castillo CR; Galvez V; Diaz R; Fernandez-Ruiz J
    Brain Imaging Behav; 2016 Mar; 10(1):252-7. PubMed ID: 25917872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3.
    Duarte JV; Faustino R; Lobo M; Cunha G; Nunes C; Ferreira C; Januário C; Castelo-Branco M
    Hum Brain Mapp; 2016 Oct; 37(10):3656-68. PubMed ID: 27273236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3.
    Suga N; Katsuno M; Koike H; Banno H; Suzuki K; Hashizume A; Mano T; Iijima M; Kawagashira Y; Hirayama M; Nakamura T; Watanabe H; Tanaka F; Sobue G
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):628-39. PubMed ID: 23617879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease.
    Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
    D'Abreu A; França MC; Yasuda CL; Campos BA; Lopes-Cendes I; Cendes F
    J Neuroimaging; 2012 Jul; 22(3):285-91. PubMed ID: 21699609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre-ataxic spinocerebellar ataxia type 3.
    Kollmer J; Weiler M; Sam G; Faber J; Hayes JM; Heiland S; Bendszus M; Wick W; Jacobi H
    Eur J Neurol; 2022 Jun; 29(6):1782-1790. PubMed ID: 35224825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flattened facial colliculus on magnetic resonance imaging in Machado-Joseph disease.
    Ogawa Y; Ito S; Makino T; Kanai K; Arai K; Kuwabara S
    Mov Disord; 2012 Jul; 27(8):1041-6. PubMed ID: 22693147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus.
    Rüb U; de Vos RA; Schultz C; Brunt ER; Paulson H; Braak H
    Brain; 2002 Sep; 125(Pt 9):2115-24. PubMed ID: 12183356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography (PET) in Machado-Joseph disease.
    Taniwaki T; Sakai T; Kobayashi T; Kuwabara Y; Otsuka M; Ichiya Y; Masuda K; Goto I
    J Neurol Sci; 1997 Jan; 145(1):63-7. PubMed ID: 9073030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
    Evert BO; Schelhaas J; Fleischer H; de Vos RA; Brunt ER; Stenzel W; Klockgether T; Wüllner U
    Clin Neuropathol; 2006; 25(6):272-81. PubMed ID: 17140157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse associations between cerebellar inhibition and motor impairment in spinocerebellar ataxia type 3.
    Maas RPPWM; van de Warrenburg BPC; Schutter DJLG
    Brain Stimul; 2021; 14(2):351-357. PubMed ID: 33535082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3.
    Maas RPPWM; Schutter DJLG; van de Warrenburg BPC
    Cerebellum; 2021 Dec; 20(6):887-895. PubMed ID: 33694049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.